Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 1468-1472, October 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Irving, C. C.
Right arrow Articles by Wiseman, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Irving, C. C.
Right arrow Articles by Wiseman, R., Jr.

Influence of 3-Methylcholanthrene and Diet on the Binding of 2-Acetylaminofluorene and Its N-Hydroxy Metabolite to Rat Liver Nucleic Acids1

Charles C. Irving, Thelma C. Peeler, Richard A. Veazey and Ralph Wiseman, Jr.

Veterans Administration Hospital and Department of Biochemistry, University of Tennessee, Memphis, Tennessee 38104

The effect of 3-methylcholanthrene (MC), which inhibits liver carcinogenesis induced by 2-acetylaminofluorene (AAF) but not by N-hydroxy-AAF, on the binding of these hepatocarcinogens to rat liver rRNA and DNA has been studied. When MC was fed in the diet at a level of 0.005% for 1 week prior to injection of AAF-9-14C or N-hydroxy-AAF-9-14C, a 45% decrease in the binding of AAF to rRNA and DNA at 16 hr was obtained, whereas there was no decrease in the binding of N-hydroxy-AAF. These data were consistent with the hypothesis that MC inhibits AAF hepatocarcinogenesis by causing a decrease in tissue levels of N-hydroxy-AAF. The extent of persistent binding of fluorenyl metabolites to DNA 4 weeks after a single injection of AAF-9-14C and N-hydroxy-AAF-9-14C was not influenced by feeding MC in the diet. Contrary to the results obtained by feeding MC, a single i.p. injection of MC (20 mg/kg) 24 hr prior to injection of the 14C-labeled hepatocarcinogens resulted in a 40% decrease in the binding of N-hydroxy-AAF to liver rRNA and DNA; a 50% decrease in the binding of AAF-9-14C to rRNA and DNA was also obtained. The differential effect on the binding of N-hydroxy-AAF-9-14C obtained by feeding or i.p. injection of MC suggested that MC in larger doses may influence some metabolic reactions involved in the activation or deactivation of N-hydroxy-AAF. Changes in diet also had significant influence on the binding of AAF-9-14C and N-hydroxy-AAF-9-14C to rat liver rRNA and DNA. In rats fed a grain diet, there was decreased binding of these hepatocarcinogens to rRNA and increased binding to DNA compared to results obtained in rats fed a commercial laboratory diet. Ingestion of the grain diet did not affect tumorigenesis in male rats fed AAF or N-hydroxy-AAF or in female rats fed AAF but did increase the incidence and distribution of tumors in female rats fed N-hydroxy-AAF.

1 Supported by the United States Veterans Administration and USPHS Research Grant CA-05490 from the National Cancer Institute.

Received 4/ 2/71. Accepted 5/28/71.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.